Trulieve Cannabis Corp. (NYSE:TRLV – Get Free Report) gapped up before the market opened on Wednesday . The stock had previously closed at $9.40, but opened at $10.00. Trulieve Cannabis shares last traded at $9.68, with a volume of 153,358 shares trading hands.
Analysts Set New Price Targets
Separately, Weiss Ratings began coverage on shares of Trulieve Cannabis in a report on Tuesday. They issued a “sell (d-)” rating on the stock. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.
Check Out Our Latest Report on Trulieve Cannabis
Trulieve Cannabis Price Performance
About Trulieve Cannabis
Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.
Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.
Read More
- Five stocks we like better than Trulieve Cannabis
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
